粤万年青：预计2025年亏损200万元–400万元

Group 1 - The company expects a loss of 2.00 million to 4.00 million yuan in 2025, with a non-recurring loss of 15.00 million to 20.00 million yuan [1] - The primary reason for the performance change is that the newly expanded health consumer products and medical health business segments are still in the market cultivation phase, leading to high fixed cost allocation and a temporary impact on overall profits [1] - The estimated impact of non-recurring gains and losses on net profit during the reporting period is approximately 13.00 million to 16.00 million yuan [1]